Literature DB >> 17922613

Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis.

Bruno Maranda1, Gilles Chabot, Jean-Claude Décarie, Monica Pata, Bouziane Azeddine, Alain Moreau, Jean Vacher.   

Abstract

UNLABELLED: Infantile ARO is a genetic disorder characterized by osteoclast dysfunction that leads to osteopetrosis. We describe a novel mutation affecting the OSTM1 locus responsible for ARO. In addition to common clinical features of osteopetrosis, the patient developed a unique neuronal pathology that provided evidence for an essential role of OSTM1 in normal neuronal cell development.
INTRODUCTION: Infantile autosomal recessive osteopetrosis (ARO) is a genetic disorder characterized by osteoclast dysfunction that leads to osteopetrosis. We describe a novel mutation affecting the OSTM1 locus responsible for ARO. In addition to common clinical features of osteopetrosis, the patient developed a unique neuronal pathology that provided evidence for an essential role of OSTM1 in normal neuronal cell development.
MATERIALS AND METHODS: We report a new case of ARO caused by an homozygous mutation in OSTM1. In addition to osteopetrosis and bone marrow failure, this patient also had neurological impairment not related to bone entrapment. Retinal dystrophy with absent evoked visual potentials and sensorineural deafness were documented, as well as cerebral atrophy and bilateral atrial subependymal heterotopias.
RESULTS: The patient developed generalized seizures and had a profound developmental delay. Nerve biopsy failed to show inclusion material suggestive of neuroaxonal dystrophy. Bone marrow transplantation was declined considering the severe neurological compromise. The patient died at 1 yr of age. Osteoclasts derived from peripheral blood were mature and multinucleated. Expression analysis showed that the amount of OSTM1 cDNA transcript was significantly lowered but not absent.
CONCLUSIONS: These results support the role of OSTM1 in osteoclast function and activation. However, they also suggest that OSTM1 has a primary role in neural development not related to lysosomal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17922613     DOI: 10.1359/jbmr.071015

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

1.  Role of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking.

Authors:  Subramanya N M Pandruvada; Janie Beauregard; Suzanne Benjannet; Monica Pata; Claude Lazure; Nabil G Seidah; Jean Vacher
Journal:  Mol Cell Biol       Date:  2015-11-23       Impact factor: 4.272

Review 2.  Regulation of lysosome biogenesis and functions in osteoclasts.

Authors:  Julie Lacombe; Gérard Karsenty; Mathieu Ferron
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

3.  Impaired vibration of auditory ossicles in osteopetrotic mice.

Authors:  Sho Kanzaki; Yasunari Takada; Shumpei Niida; Yoshihiro Takeda; Nobuyuki Udagawa; Kaoru Ogawa; Nobuhito Nango; Atsushi Momose; Koichi Matsuo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Hematopoietic cell transplantation for a child with OSTM1 osteopetrosis.

Authors:  Kathleen M Overholt; Melissa J Rose; Sarita Joshi; Gail E Herman; Rajinder Bajwa; Rolla Abu-Arja; Hemalatha G Rangarajan; Edwin M Horwitz
Journal:  Blood Adv       Date:  2016-12-30

5.  Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency.

Authors:  Céline Héraud; Adam Griffiths; Subramanya N M Pandruvada; Manfred W Kilimann; Monica Pata; Jean Vacher
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

6.  A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.

Authors:  Nesrin Besbas; Markus Draaken; Michael Ludwig; Ozgur Deren; Diclehan Orhan; Yelda Bilginer; Fatih Ozaltin
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

Review 7.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

Review 8.  Osteopetrosis.

Authors:  Zornitza Stark; Ravi Savarirayan
Journal:  Orphanet J Rare Dis       Date:  2009-02-20       Impact factor: 4.123

Review 9.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

10.  OSTM1 bone defect reveals an intercellular hematopoietic crosstalk.

Authors:  Monica Pata; Céline Héraud; Jean Vacher
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.